The fundus image processing software (Fundus Image Intelligent Analysis System) independently developed by Healgoo Interactive was awarded the Medical Device Registration Certificate (Class 2) issued by Guangdong Food and Drug Administration, China on September 25, 2018.

From July 7th to 8th, 2018, Healgoo Interactive was invited to participate in the 3rd Asia Pacific Tele-Ophthalmology Society (APTOS) symposium in Singapore, focusing on the progress of application of Big Data Analytics and Artificial Intelligence (AI) in the field of ophthalmology. Experts and industry elites from all over the world started a two-day exchange and discussion.

On July 5th, Vcbeat.net conducted an exclusive interview with Healgoo Interactive Artificial Intelligence products. The following is the content of the interview.

On July 2, 2018, Healgoo Interactive announced that the artificial intelligence training platform Healgoo ML has officially started operations. The Healgoo ML platform has accumulated many years of research and experience in the field of AI, which will help users to easily build their own AI system.

Healgoo Interactive Med-Tech, as a research and development enterprise dedicated to the research and application of medical big data and artificial intelligence diagnosis technology, with strong research and development team, advanced management level and innovative consciousness of continuous research and exploration in the field of medical science and technology, in line with the relevant provisions of the "National High-Tech Enterprise Identification and Management Measures" and "Guidelines for the Identification and Management of High-Tech Enterprises", was officially awarded the certificate of "High-Tech Enterprise" jointly issued by Guangdong provincial science and technology office, Guangdong provincial department of finance, Guangdong provincial state taxation bureau and Guangdong provincial local taxation bureau on May 2, 2018.

On 1st of March 2018, Healgoo Interactive formally established Healgoo AI Remote Reading Center (manual grading + AI support) to provide remote reading services focusing on diabetic retinopathy and various kinds of fundus diseases

On November 29, Leiphone.com made an exclusive interview with Healgoo Interactive for Healgoo AI products. The following is the published interview content.

Healgoo Interactive as a professional medical technology company, has always attached great importance to the construction of information security system. Since obtaining the US HIPAA security certification, the company has been continuously improving and enhancing its information security work. After a long-term unremitting efforts, the company has received the ISO 27001:2013 Information Security Certification on October 30, 2017.

On 21st of July 2017, Healgoo Interactive with Healgoo AI product came to Songhe Nursing Homes (Haizhu District, Guangzhou City) to carry out a free eye screening activity. Guangdong TV "Today Focus" program did a full interview during this activity. The following is the broadcast video and text content.

China's first artificial intelligence diagnostic robot for multiple eye diseases is about to go online!

DIA 2017 Annual meeting has come to another fruitful end.

Eligibility

Lifeline Express Diabetic Retinopathy Screening Program has prevented visual loss in many patients with diabetes. Healgoo’s Eye Grader as the designated tool for this program, has supported eye care health professionals’ work substantially.

APICTA was held in Colombo, Sri Lanka 18-22 November 2015. Delegates from diverse Asia Pacific regions gather to share exciting ideas, and Healgoo as one of the Chinese representatives bring its product Eye Grader to shine in competition in Health and Wellbeing sector.

Healgoo has always valued to protect data safety and privacy, therefore it has been designed and realized strictly based on the HIPAA standard.

Healgoo advocates for the idea of telemedicine, especially giving the inappropriate distribution of eye care resources in China. Healgoo applied for Guangdong Technological Innovation Fund for Technology-Based Medium and Small Enterprises in 2014, held responsible for the “Ophthalmology telemedical system based on artificial intelligence recognition and cloud technology” project, and dedicated to build a system optimizing the eye care access. Through the endeavours of everyone who contributed to Healgoo along the way, “Ophthalmology telemedical system based on artificial intelligence recognition and cloud technology” project has been seen through and developed.